We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.
Reference sheet · Growth Factors · CPC catalog code PAP-003
This sequence carries terminal or reporter modifications (NH2), so no molecular formula or weight is published here — the modified mass must come from the lot certificate of analysis. Residue composition and charge describe the peptide backbone only. Composition figures above are derived arithmetically from the published sequence for the unmodified free peptide. Salt forms (commonly trifluoroacetate or acetate), amidation, and other modifications shift the observed mass — always reconcile against the current lot certificate of analysis.
Volumes for a 1 mg vial of Protease-Activated Receptor-2, PAR-2 Agonist, amide at common working concentrations. Add solvent slowly down the vial wall and swirl — do not vortex or shake.
Reference standards in the Growth Factors class are typically shipped as lyophilized powder and stored desiccated at −20 °C protected from light. Once reconstituted in bacteriostatic water or the assay-appropriate buffer, aliquot and store at −80 °C to minimize freeze–thaw cycles. Confirm handling requirements against your institutional biosafety and radiation protocols before use.
Protease-Activated Receptor-2, PAR-2 Agonist, amide sits within the Growth Factors research class (CPC reference PAP-003). Growth-factor peptides activate receptor tyrosine kinases (EGFR, FGFR, VEGFR, IGF-1R) and downstream RAS–MAPK and PI3K–AKT pathways that drive proliferation, migration, and survival. Investigators typically incorporate Protease-Activated Receptor-2, PAR-2 Agonist, amide as a reference standard, tool ligand, or substrate in the assay contexts listed above. Phospho-ERK and phospho-AKT Western blots or AlphaLISA assays are the standard readouts.
Protease-Activated Receptor-2, PAR-2 Agonist, amide (CPC catalog code PAP-003) is a synthetic growth-factor / mitogen peptide in the growth factors category. It is provided as a lyophilized ~1 mg vial for in-vitro research use only.
Published and internal research programs use Protease-Activated Receptor-2, PAR-2 Agonist, amide as a reference standard in growth factors workflows — for example, proliferation and brdu / edu assays and wound-healing and scratch-closure models. Human clinical evidence is not established.
No. Protease-Activated Receptor-2, PAR-2 Agonist, amide is a research-grade reference peptide and is not approved by the FDA or any national regulator for human or veterinary therapeutic use. It is offered exclusively for in-vitro laboratory research and does not ship to the United States for consumer use.
In a growth factors workflow, Protease-Activated Receptor-2, PAR-2 Agonist, amide is reconstituted in sterile buffer or DMSO (solubility-dependent) and applied in the researcher's chosen assay format. Phospho-ERK and phospho-AKT Western blots or AlphaLISA assays are the standard readouts.
Other reference standards in the same class — commonly cross-referenced during assay design and comparator selection.